Skip to main content

Table 6 Gene model validation test by BNN analysis. Malignant or benign group allocation probability values for the unknown samples

From: The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management

Unknown samples Benign probability Malignant Probability Predicted diagnosis Cytological diagnosis Pathological diagnosis BRAF status
A 0.0302 1.0000 Malignant SPTC Malignant V600E
B 0.0011 1.0000 Malignant SPTC Malignant V600E
C 0.0004 0.9996 Malignant SPTC Malignant V600E
D 0.0000 1.0000 Malignant SPTC Malignant V600E
E 0.3242 0.6758 Malignant SPTC Malignant V600E
F 0.0223 0.9777 Malignant SPTC Malignant V600E
G 0.0009 0.9991 Malignant SPTC Malignant WT
H 0.1759 0.8241 Malignant SPTC Malignant WT
I 0.0847 0.9153 Malignant SPTC Malignant V600E
L 0.2007 0.7993 Malignant SPTC Malignant WT
M 0.0000 1.0000 Malignant SPTC Malignant WT